Stem cell co Brainstorm awarded $16m ALS grant – Globes
Globes |
Stem cell co Brainstorm awarded $16m ALS grant
Globes Israeli stem cell developer Brainstorm Cell Therapeutics Inc. (Nasdaq:BCLI) has been awarded a $16 million grant by the California Institute for Regenerative Medicine (CIRM). The grant will support a pivotal Phase III study of NurOwn, for the treatment … Grant Award Rockets Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Brainstorm Cell Therapeutics Inc. (BCLI) Stock Rating Upgraded by ValuEngine Brainstorm Cell Therapeutics Inc (BCLI) Stock Is An 52-Week High Flier |
